Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 700

The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.

BCL-2 family isoforms in apoptosis and cancer

Open access
Warren, Chloe F. A., Wong-Brown, Michelle W., Bowden, Nikola A.·2019·Cell Death & Disease

Abstract

The BCl-2 family has long been identified for its role in apoptosis. Following the initial discovery of BCL-2 in the context of B-cell lymphoma in the 1980s, a number of homologous proteins have since been identified. The members of the Bcl-2 family are designated as such due to their BCL-2 homology (BH) domains and involvement in apoptosis regulation. The BH domains facilitate the family members’ interactions with each other and can indicate pro- or anti-apoptotic function. Traditionally, these proteins are categorised into one of the three subfamilies; anti-apoptotic, BH3-only (pro-apoptotic), and pore-forming or ‘executioner’ (pro-apoptotic) proteins. Each of the BH3-only or anti-apoptotic proteins has a distinct pattern of activation, localisation and response to cell death or survival stimuli. All of these can vary across cell or stress types, or developmental stage, and this can cause the delineation of the roles of BCL-2 family members. Added to this complexity is the presence of relatively uncharacterised isoforms of many of the BCL-2 family members. There is a gap in our knowledge regarding the function of BCL-2 family isoforms. BH domain status is not always predictive or indicative of protein function, and several other important sequences, which can contribute to apoptotic activity have been identified. While therapeutic strategies targeting the BCL-2 family are constantly under development, it is imperative that we understand the molecules, which we are attempting to target. This review, discusses our current knowledge of anti-apoptotic BCL-2 family isoforms. With significant improvements in the potential for splicing therapies, it is important that we begin to understand the distinctions of the BCL-2 family, not limited to just the mechanisms of apoptosis control, but in their roles outside of apoptosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-019-1407-6

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 139 references

Research works printed but not linked: 11

  1. Alberts, B., Molecular Biology of the Cell: Reference Edition (Taylor & Francis, New York, NY, USA 2008).
  2. Ban, J. et al. Identification of a human cDNA encoding a novel Bcl-x isoform. Biochem. Biophys. Res. Commun. 248, 147–152 (1998). · doi:10.1006/bbrc.1998.8907
  3. Massiello, A. et al. Identification of two RNA cis-elements that function to regulate the 5’ splice site selection of Bcl-x pre-mRNA in response to ceramide. J. Biol. Chem. 279, 15799–15804 (2004). · doi:10.1074/jbc.m313950200
  4. Kim, M. H. Protein phosphatase 1 activation and alternative splicing of Bcl-X and Mcl-1 by EGCG + ibuprofen. J. Cell. Biochem. 104, 1491–1499 (2008). · doi:10.1002/jcb.21725
  5. Peng, J. et al. The Bax BH3 peptide H2-H3 promotes apoptosis by inhibiting Bcl-2’s pore-forming and anti-Bax activities in the membrane. Sheng Wu Yi Xue Gong. Cheng Xue Za Zhi 26, 829–835 (2009).
  6. Massaad, C. A., Portier, B. P. & Taglialatela, G. Inhibition of transcription factor activity by nuclear compartment-associated Bcl-2. J. Biol. Chem. 279, 54470–54478 (2004). · doi:10.1074/jbc.m407659200
  7. Kawatani, M. et al. Transmembrane domain of Bcl-2 is required for inhibition of ceramide synthesis, but not cytochrome c release in the pathway of inostamycin-induced apoptosis. Exp. Cell Res. 286, 57–66 (2003). · doi:10.1016/s0014-4827(03)00098-3
  8. Yamaguchi, R. & Perkins, G. Mcl-1 levels need not be lowered for cells to be sensitized for ABT-263/737-induced apoptosis. Cell Death Dis. 2, e227 (2011). · doi:10.1038/cddis.2011.109
  9. España, L. et al. Overexpression of Bcl-xL in Human Breast Cancer Cells Enhances Organ-Selective Lymph Node Metastasis. Breast Cancer Res. Treat. 87, 33–44 (2004). · doi:10.1023/b:brea.0000041579.51902.89
  10. Ko, J. K. et al. Bfl-1S, a novel alternative splice variant of Bfl-1, localizes in the nucleus via its C-terminus and prevents cell death. Oncogene 22, 2457–2465 (2003). · doi:10.1038/sj.onc.1206274
  11. Jin, Z. et al. Bcl2 suppresses DNA repair by enhancing c-Myc transcriptional activity. J. Biol. Chem. 281, 14446–14456 (2006). · doi:10.1074/jbc.m511914200

Cited by

See all 700

Metadata

Authors
Warren, C. F. A., Wong-Brown, M. W., & Bowden, N. A.
Venue
Cell Death & Disease
Published
2019-02-21
Volume
10
Issue
3
Pages
177-177
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2916911849
Cited by
700
References
139
FWCI
20.70
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • Cancer Institute NSW (14CDF117)
  • Hunter Medical Research Institute
  • University of Newcastle Priority Research Centre for Cancer Research Innovation and Translation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BCL-2 family isoforms in apoptosis and cancer. https://app.cochat.ai/papers/10.1038/s41419-019-1407-6
The paper
Warren, C. F. A., Wong-Brown, M. W., & Bowden, N. A. (2019). BCL-2 family isoforms in apoptosis and cancer. Cell Death & Disease. https://doi.org/10.1038/s41419-019-1407-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.